InSightec lands insurance coverage for ExAblate

MR-guided focused ultrasound developer InSightec announced that Health Care Service (HCSC) has updated its coverage policy to include InSightec's ExAblate procedure as a treatment option for patients with bone metastases.

HCSC is the second largest Blue Cross/Blue Shield commercial insurer in the U.S.

Page 1 of 611
Next Page